In this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the importance of shared decision making and explains the differences between yesterday's and today's care.

Linda Siminerio discusses her role as chair of the national diabetes education program and involvement clinically and in research in looking at self-management and healthcare delivery models for diabetes care.

In part 1 of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the changes in diabetes care over the years.

In part 2 of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about communication with diabetes patients then and now.

In part 3 of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California. Dr. Siminerio shares her choice for the most life-changing technology for patients.

In part 4 of this Exclusive Interview, Dr. Linda Siminerio explains the most important part of patient care in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 5, the conclusion, of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about care for the prediabetes patient and the importance of doctors conveying the severity of the situation.

In part 6, the conclusion, of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about her presentation goals for the provider audience.

If you put glycocalyx in Google search, you will find a definition that includes “a glycoprotein covering that surrounds the cell membranes of some bacteria, epithelia and other cells.” This does not make much sense when you’re trying to help prevent kidney disease, but this glycoprotein has a lot to do with …

Drs. Sood and Messer discuss the takeaways from their presentation with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. They also share the advantages of working for a large organization versus private practice.